Sun Pharma reached an agreement with Celgene Corporation (Celgene) in June 2021 to settle the patent litigation involving Sun Pharma's generic lenalidomide capsules.
Despite a drop in US sales, consolidated revenue increased by 3.9% y-o-y to Rs 4,322 crore in Q3FY23.
However, the pharma company did not disclosed the price at which the stake was sold.
The company declared an interim dividend of Rs7.50 per equity share for the fiscal year 2022-23.
On December 12, last year, the company initiated a Class II nationwide (US) recall of the affected lot.
In India, Wipro and GE Healthcare operate as a joint venture.
Deuruxolitinib, Concert's lead candidate, is getting tested as a treatment for the autoimmune condition alopecia areata.
Cidmus tablets are available in three strengths: 50mg, 100mg, and 200mg, and should be taken twice a day.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
